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‘Instruction to Authors’ in HIR. The section consists of four 
parts: ‘Research ethics,’ ‘Authorship,’ ‘Conflict of interest,’ 
and ‘Copyright policy.’ Prohibition of redundant publication 
is mentioned in the ‘Editorial policy’ section of the ‘Edito-
rial and Review Policy’ section. Each manuscript is peer re-
viewed by three anonymous reviewers selected by the editor 
and associate editors (‘Peer-review process’ part). General 
ethical guidelines in HIR are described in the ‘Research 
ethics’ section, asking authors to provide IRB approval and 
Helsinki declaration compliance in human subject studies 
and for fields of research such as animal studies that were 
not mentioned directly. HIR adopted the guidelines “Good 
Publication Practice Guidelines for Medical Journals,” 
“Guidelines on Good Publication Practice (The COPE Re-
port, 2003),” and “Uniform Requirements for Manuscripts 
Submitted to Biomedical Journals: Writing and Editing for 
Biomedical Publication” from The International Committee 
of Medical Journal Editors (ICMJE) [4] regarding research 
and publication ethics.
  Publication ethics guidelines are described as falling into 
categories of research ethics, publication ethics (authorship 
and review process), and dealing with misconduct. Since the 
‘Instruction to Authors’ in HIR provides a guideline for au-
thors but not for reviewers and editors, and in order to create 
a process for editors and reviewers to deal with misconduct, 
the relevant sections should be supplemented, although a 
general flow for dealing with this subject has been included 
in HIR. Generally speaking, in terms of ethical aspects, the 
‘Instruction to Authors’ section in HIR has adopted guide-
lines similar to those of other informatics journals such as 
the Journal of American Medical Informatics Association 
(JAMIA) and the International Medical Informatics Associa-
tion (IMIA). It will be better if other guidelines and standard 
operating procedures are established in compliance with 
ethical guidelines based on HIR ethics policies. The HIR 
editorial board will make an effort to implement good pub-
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The Hwang Woo Suk scandal in the field of stem cell re-
search reminded us of ethical consideration in research and 
publication. The scandal, in which fabricated papers and 
unethical donation of human oocytes were the main issues, 
had a large social impact worldwide, as well as in Korea. It 
was quite a shock to scientific society in Korea, as there had 
been efforts to establish ethical guidelines in the research 
field even before the scandal. The Korean Association of In-
stitutional Review Boards (KAIRB) was founded in March 
2002 under the auspices of the Korean Academy of Medical 
Sciences to bring the level of Korean IRBs up to the inter-
national standard. The Bioethics and Biosafety Act of 2003 
was put into effect at the beginning of 2005 [1], even though 
some researchers thought that ethical guidelines were a bar-
rier to the development of science [2]. These actions resulted 
in an establishment of guidelines for ethics in research and 
publication in many fields. One of the guidelines, “Good 
Publication Practice Guidelines for Medical Journals,” issued 
in 2008 [3], was also adopted as part of Health Informatics 
Research (HIR)’s ethics guidelines. 
  In the field of healthcare informatics research, the HIR 
editorial board aims to publish high quality articles without 
any ethical problems. Recently, HIR editors have decided to 
review the HIR author’s submission guidelines, including 
aspects of the ethical view. HIR also held a session for pub-
lication ethics in a 2011 annual symposium with two invited 
specialists, Chang Gok Hahm (Chung-Ang University Col-
lege of Medicine, Seoul, Korea) and Eun Sung Hwang (Uni-
versity of Seoul, Seoul, Korea). Based on discussions about 
the ethics surrounding the review of submitted articles, an 
‘Ethical Considerations’ section was introduced into the 2 http://dx.doi.org/10.4258/hir.2012.18.1.1 www.e-hir.org
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lication practices and to pursue a high quality journal. We 
also look forward to HIR members’ efforts, as this journal is 
a collaboration, a result of all HIR members’ endeavors and 
concerns.
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